Dave(DAVE) GlobeNewswire News Room·2025-03-18 17:12Core Insights - NeuroOne Medical Technologies Corporation is focused on improving surgical care for patients with neurological disorders, particularly epilepsy, through innovative technology [1][5] - The company’s OneRF® Ablation System is the first FDA 510(k)-cleared device that can record brain activity and perform RF ablation simultaneously, representing a significant advancement in epilepsy treatment [3][4] Industry Overview - Over 50 million people globally are affected by epilepsy, with nearly one-third experiencing seizures that do not respond to medication, highlighting a substantial need for alternative treatment options [2] - Radiofrequency (RF) ablation therapy is emerging as a promising solution for patients who do not respond to traditional medication [2] Company Technology - The OneRF® system consists of three main components: an electrode for stimulation and monitoring, a temperature probe, and a radio frequency heat generator [3] - The system aims to improve patient outcomes by combining real-time monitoring with targeted ablation in a single procedure, potentially reducing the need for multiple invasive surgeries [4] Future Applications - NeuroOne is also exploring the potential of its technology for applications beyond epilepsy, including pain management and other neurological disorders such as Parkinson's disease and chronic pain [5]